Implementation of strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in U.S. hospitals.

Published

Journal Article

OBJECTIVE: To examine the extent to which the strategies recommended by the National Foundation for Infectious Diseases (NFID)-Centers for Disease Control and Prevention (CDC) co-sponsored workshop, Antimicrobial Resistance in Hospitals: Strategies to Improve Antimicrobial Use and Prevent Nosocomial Transmission of Antimicrobial-Resistant Microorganisms, have been implemented and the relationship between the degree of implementation and hospital culture, leadership, and organizational factors. DESIGN: Survey. SETTING: A representative sample of U.S. hospitals stratified by teaching status, bed size, and geographic region. PARTICIPANTS: Infection control professionals. RESULTS: Surveyed hospitals had implemented strategies to optimize the use of antimicrobials and to detect, report, and prevent transmission of antimicrobial-resistant microorganisms. Multivariate analyses found that hospitals with a greater degree of implementation of the NFID-CDC strategic goals were more likely to have management support, education of staff, and interdisciplinary groups specifically to address these issues; they were also more likely to engage in benchmarking on broader quality of care indicators. CONCLUSIONS: Most surveyed hospitals had implemented some measures to address the NFID-CDC recommendations; however, hospitals need to do much more to improve antimicrobial use and to increase their efforts to detect, report, and control the spread of antimicrobial resistance. A supportive hospital administration must foster a culture of ongoing support, education, and interdisciplinary work groups focused on this important issue to successfully accomplish these goals.

Full Text

Duke Authors

Cited Authors

  • Ward, MM; Diekema, DJ; Yankey, JW; Vaughn, TE; BootsMiller, BJ; Pendergast, JF; Doebbeling, BN

Published Date

  • January 2005

Published In

Volume / Issue

  • 26 / 1

Start / End Page

  • 21 - 30

PubMed ID

  • 15693405

Pubmed Central ID

  • 15693405

International Standard Serial Number (ISSN)

  • 0899-823X

Digital Object Identifier (DOI)

  • 10.1086/502483

Language

  • eng

Conference Location

  • United States